Hodge JW - Search Results

1

The tipping point for combination therapy: cancer vaccines with radiation, chemotherapy, or targeted small molecule inhibitors.

Hodge JW, Ardiani A, Farsaci B, Kwilas AR, Gameiro SR. Hodge JW, et al. Semin Oncol. 2012 Jun;39(3):323-39. doi: 10.1053/j.seminoncol.2012.02.006. Semin Oncol. 2012. PMID: 22595055 Free PMC article. Review.

2

Carcinoembryonic antigen as a target for cancer vaccines.

Hodge JW. Hodge JW. Cancer Immunol Immunother. 1996 Nov;43(3):127-34. doi: 10.1007/s002620050313. Cancer Immunol Immunother. 1996. PMID: 9001565 Review.

3

Strategies in the development of recombinant vaccines for colon cancer.

Schlom J, Tsang KY, Kantor JA, Abrams SI, Zaremba S, Greiner J, Hodge JW. Schlom J, et al. Among authors: hodge jw. Semin Oncol. 1999 Dec;26(6):672-82. Semin Oncol. 1999. PMID: 10606260 Review.

4

Vector-based vaccine/cytokine combination therapy to enhance induction of immune responses to a self-antigen and antitumor activity.

Aarts WM, Schlom J, Hodge JW. Aarts WM, et al. Among authors: hodge jw. Cancer Res. 2002 Oct 15;62(20):5770-7. Cancer Res. 2002. PMID: 12384537

5

General keynote: vaccine strategies for the therapy of ovarian cancer.

Hodge JW, Tsang KY, Poole DJ, Schlom J. Hodge JW, et al. Gynecol Oncol. 2003 Jan;88(1 Pt 2):S97-104; discussion S110-3. doi: 10.1006/gyno.2002.6694. Gynecol Oncol. 2003. PMID: 12586096 Review. No abstract available.

6

Intratumoral vaccination and diversified subcutaneous/ intratumoral vaccination with recombinant poxviruses encoding a tumor antigen and multiple costimulatory molecules.

Kudo-Saito C, Schlom J, Hodge JW. Kudo-Saito C, et al. Among authors: hodge jw. Clin Cancer Res. 2004 Feb 1;10(3):1090-9. doi: 10.1158/1078-0432.ccr-03-0145. Clin Cancer Res. 2004. PMID: 14871989

7

External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated T-cell killing.

Chakraborty M, Abrams SI, Coleman CN, Camphausen K, Schlom J, Hodge JW. Chakraborty M, et al. Among authors: hodge jw. Cancer Res. 2004 Jun 15;64(12):4328-37. doi: 10.1158/0008-5472.CAN-04-0073. Cancer Res. 2004. PMID: 15205348

8

Induction of an antigen cascade by diversified subcutaneous/intratumoral vaccination is associated with antitumor responses.

Kudo-Saito C, Schlom J, Hodge JW. Kudo-Saito C, et al. Among authors: hodge jw. Clin Cancer Res. 2005 Mar 15;11(6):2416-26. doi: 10.1158/1078-0432.CCR-04-1380. Clin Cancer Res. 2005. PMID: 15788693

9

Combining a recombinant cancer vaccine with standard definitive radiotherapy in patients with localized prostate cancer.

Gulley JL, Arlen PM, Bastian A, Morin S, Marte J, Beetham P, Tsang KY, Yokokawa J, Hodge JW, Ménard C, Camphausen K, Coleman CN, Sullivan F, Steinberg SM, Schlom J, Dahut W. Gulley JL, et al. Among authors: hodge jw. Clin Cancer Res. 2005 May 1;11(9):3353-62. doi: 10.1158/1078-0432.CCR-04-2062. Clin Cancer Res. 2005. PMID: 15867235 Clinical Trial.

10

The requirement of multimodal therapy (vaccine, local tumor radiation, and reduction of suppressor cells) to eliminate established tumors.

Kudo-Saito C, Schlom J, Camphausen K, Coleman CN, Hodge JW. Kudo-Saito C, et al. Among authors: hodge jw. Clin Cancer Res. 2005 Jun 15;11(12):4533-44. doi: 10.1158/1078-0432.CCR-04-2237. Clin Cancer Res. 2005. PMID: 15958639

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

188 results

Search Page